Market insights & investment news

Dive into the latest market news and views from the Freetrade team.

February 26, 2021

Has Fundsmith made the Rightmove?

Record traffic but falling profits leave Rightmove facing key questions.

February 24, 2021

SPAC madness hits Churchill-Lucid merger

SPACs: hype, risks, and how to judge blank-cheque deals before buying wisely now

February 23, 2021

Cellular Goods IPO

Cellular Goods joins the LSE amid CBD hype, big plans, no products yet and real risks.

February 22, 2021

Deliveroo IPO: what you need to know

Deliveroo eyes a timely IPO after fast growth, new partners and rising sector demand.

February 22, 2021

Coke’s weird origins

Coca-Cola’s long rise continues, but sugar taxes and health trends test future growth.

February 18, 2021

Are UK banks a buy?

UK banks face loan risks and low rates while recovery hopes and returning dividends lift sentiment.

February 17, 2021

Why did Palantir shares crash on Tuesday?

Palantir’s growth slows, losses persist and lockup expiry spooks investors

February 15, 2021

Why the pot stock rally just ended

Cannabis stocks spike then sink as mergers, hype and law change collide

February 15, 2021

The chipmaker at the heart of US-China tensions

TSMC: chip boom winner caught between US–China rivalry and supply shocks

February 11, 2021

Can Bumble IPO buzz topple Tinder?

Bumble’s IPO marks a big step in its challenge to Tinder. Here’s what the app’s numbers, strategy and expansion plans reveal for potential investors.

February 11, 2021

AstraZeneca is back in growth mode

Why AstraZeneca’s share price isn’t rising with its vaccine progress.

February 9, 2021

Ocado: the tech giant hiding in plain sight

Ocado grows earnings as retail surges, but its tech arm still tests patience

Tools & more

Tools & Calculators

Helpful tools and resources for every kind of investor.

Dictionary

Simple explanations for complicated jargon.